Zacks Research Issues Positive Estimate for Amgen Earnings
Amgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Amgen in a research report issued to clients and investors on Tuesday, February 25th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings of $5.22 per […]
